Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 34
Filtrar
1.
Clin Microbiol Infect ; 25(5): 546-554, 2019 May.
Artigo em Inglês | MEDLINE | ID: mdl-30448331

RESUMO

BACKGROUND: Fluoroquinolones are a popular alternative to trimethoprim-sulfamethoxazole for Stenotrophomonas maltophilia infections. OBJECTIVES: To compare the effects of fluoroquinolones and trimethoprim-sulfamethoxazole on mortality of S. maltophilia infections. DATA SOURCES: PubMed and EMBASE. STUDY ELIGIBILITY CRITERIA: Clinical studies reporting mortality outcomes of S. maltophilia infections. PARTICIPANTS: Patients with clinical infections caused by S. maltophilia. INTERVENTIONS: Fluoroquinolone monotherapy in comparison with trimethoprim-sulfamethoxazole monotherapy. METHODS: Systematic review with meta-analysis technique. RESULTS: Seven retrospective cohort and seven case-control studies were included. Three cohort studies were designed to compare the two drugs, whereas others had other purposes. A total of 663 patients were identified, 332 of which were treated with trimethoprim-sulfamethoxazole (50.1%) and 331 with fluoroquinolones (49.9%). Three cohort studies were designed to compare the effect of the two drugs, whereas the others had other purposes. Levofloxacin was most frequently used among fluoroquinolones (187/331, 56.5%), followed by ciprofloxacin (114/331, 34.4%). The overall mortality rate was 29.6%. Using pooled ORs for the mortality of each study, fluoroquinolone treatment (OR 0.62, 95% CI 0.39-0.99) was associated with survival benefit over trimethoprim-sulfamethoxazole treatment, with low heterogeneity (I2 = 18%). Specific fluoroquinolones such as ciprofloxacin (OR 0.44, 95% CI 0.17-1.12) and levofloxacin (OR 0.78, 95% CI 0.48-1.26) did not show a significant difference in comparison with trimethoprim-sulfamethoxazole. In the sub-group analyses of adult and bacteraemic patients, significant differences in mortality were not observed between fluoroquinolones and trimethoprim-sulfamethoxazole. CONCLUSIONS: Based on a meta-analysis of non-randomized studies, fluoroquinolones demonstrated comparable effects on mortality of S. maltophilia infection to trimethoprim-sulfamethoxazole, supporting the use of fluoroquinolones in clinical S. maltophilia infections. Although the pooled analysis of overall studies favoured fluoroquinolones over trimethoprim-sulfamethoxazole, the studies included were observational, and sub-group analyses of certain fluoroquinolone agents did not show statistical differences with trimethoprim-sulfamethoxazole. Randomized clinical studies are needed to address these issues.


Assuntos
Antibacterianos/uso terapêutico , Fluoroquinolonas/uso terapêutico , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Infecções por Bactérias Gram-Negativas/mortalidade , Stenotrophomonas maltophilia/efeitos dos fármacos , Combinação Trimetoprima e Sulfametoxazol/uso terapêutico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Feminino , Infecções por Bactérias Gram-Negativas/microbiologia , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Stenotrophomonas maltophilia/isolamento & purificação , Análise de Sobrevida , Resultado do Tratamento , Adulto Jovem
2.
Eur J Clin Microbiol Infect Dis ; 36(10): 1947-1953, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28577158

RESUMO

This study was conducted to investigate the adherence to clinical practice guidelines (CPGs) for Clostridium difficile infection (CDI). A retrospective multicenter observational study was conducted via chart review at four teaching hospitals in Japan from April 2012 through September 2013. CDI was diagnosed based on positive identification of CD toxin by enzyme immunoassay testing. CDI patients were divided into non-severe and severe groups according to the severity criteria of four published guidelines (SHEA/IDSA 2010, ACG 2013, ESCMID 2009, HPA/DH 2008). Three parameters were assessed in association with disease severity: adherence to treatment guidelines, prognosis, and relapse rate. In total, 170 patients were diagnosed with CDI (1.04 cases per 10,000 patient-days). The 30-day all-cause mortality and recurrence rates were 13% and 14%, respectively. CPGs adherence ranged from 52% to 70% in the non-severe group and from 8.5 to 23% in the severe group (P < 0.01). Among severe CDI patients, no significant difference in mortality or recurrence was found between the patients whose treatments adhered and did not adhere to the CPGs. CPGs adherence was low, especially for patients with severe CDI. Improved guideline adherence and more accurate definitions of severity based on prognosis are needed for appropriate CDI management.


Assuntos
Infecções por Clostridium/diagnóstico , Infecções por Clostridium/tratamento farmacológico , Gerenciamento Clínico , Fidelidade a Diretrizes , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Pesquisa sobre Serviços de Saúde , Hospitais de Ensino , Humanos , Japão , Masculino , Pessoa de Meia-Idade , Recidiva , Estudos Retrospectivos , Análise de Sobrevida , Adulto Jovem
3.
J Hosp Infect ; 96(1): 29-34, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-28377180

RESUMO

BACKGROUND: Analysis of bloodstream infections (BSIs) is valuable for their diagnosis, treatment and prevention. However, limited data are available in Japan. AIM: To investigate the characteristics of patients with bacteraemia in Japan. METHODS: This study was conducted in five hospitals from October 2012 to September 2013. Clinical, demographic, microbiological and outcome data for all blood-culture-positive cases were analysed. FINDINGS: In total, 3206 cases of BSI were analysed: 551 community-onset healthcare-associated (CHA)-BSIs, 1891 hospital-acquired (HA)-BSIs and 764 community-acquired (CA)-BSIs. The seven- and 30-day mortality rates were higher in patients with CHA- and HA-BSIs than in patients with CA-BSIs. The odds ratios (ORs) for seven-day mortality were 2.56 [95% confidence interval (CI) 1.48-4.41] and 2.63 (95% CI 1.64-4.19) for CHA- and HA-BSIs, respectively. The ORs for 30-day mortality were 2.41 (95% CI 1.63-3.57) and 3.31 (95% CI 2.39-4.59) for CHA- and HA-BSIs, respectively. There were 499 cases (15.2%) of central-line-associated BSI and 163 cases (5.0%) of peripheral-line-associated BSI. Major pathogens included coagulase-negative staphylococci (N = 736, 23.0%), Escherichia coli (N = 581, 18.1%), Staphylococcus aureus (N = 294, 9.2%) and Klebsiella pneumoniae (N = 263, 8.2%). E. coli exhibited a higher 30-day mortality rate among patients with HA-BSIs (22.3%) compared with patients with CHA-BSIs (12.3%) and CA-BSIs (3.4%). K. pneumoniae exhibited higher 30-day mortality rates in patients with HA-BSIs (22.0%) and CHA-BSIs (22.7%) compared with patients with CA-BSIs (7.8%). CONCLUSION: CHA- and HA-BSIs had higher mortality rates than CA-BSIs. The prognoses of E. coli- and K. pneumonia-related BSIs differed according to the category of bacteraemia.


Assuntos
Bacteriemia/epidemiologia , Patógenos Transmitidos pelo Sangue/isolamento & purificação , Infecções Relacionadas a Cateter/microbiologia , Infecções Comunitárias Adquiridas/epidemiologia , Infecções Comunitárias Adquiridas/microbiologia , Infecção Hospitalar/epidemiologia , Idoso , Idoso de 80 Anos ou mais , Bacteriemia/microbiologia , Bacteriemia/mortalidade , Patógenos Transmitidos pelo Sangue/efeitos dos fármacos , Infecções Relacionadas a Cateter/epidemiologia , Infecções Relacionadas a Cateter/mortalidade , Infecções Comunitárias Adquiridas/mortalidade , Infecção Hospitalar/mortalidade , Escherichia coli/isolamento & purificação , Feminino , Humanos , Japão/epidemiologia , Klebsiella pneumoniae/isolamento & purificação , Masculino , Pessoa de Meia-Idade , Mortalidade , Avaliação de Resultados em Cuidados de Saúde , Estudos Prospectivos , Staphylococcus aureus/isolamento & purificação
4.
J Wound Care ; 19(8): 361-4, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20852510

RESUMO

OBJECTIVE: To illustrate the association between hydroxyurea and the development of ulcers. METHOD: A case study is presented, in which histological changes, mean corpuscular volume (MCV) and transcutaneous oxygen tension (TcPO2) were all measured and analysed, both during hydroxyurea treatment and following it's discontinuation. RESULTS: Two months following the cessation of hydroxyurea therapy, the patient's ulcer had healed completely. Biopsy specimens taken before and after its discontinuation showed a considerable improvement in vascularity, with a capillary density 6.28 times higher after discontinuation of the drug. TcPO2 was just 8mmHg at the first measurement, and this increased to 65mmHg at the second. CONCLUSION: These findings suggest deficient neovascularisation and circulation during hydroxyurea treatment. Changes in MCV also appeared to have an effect on the progress of wound healing, which supports the hypothesis that macroerythrocytosis may be involved in the development of these rare ulcers, via impairment of the microcirculatory rheology.


Assuntos
Úlcera do Pé/induzido quimicamente , Hidroxiureia/efeitos adversos , Inibidores da Síntese de Ácido Nucleico/efeitos adversos , Trombocitemia Essencial/tratamento farmacológico , Idoso , Biópsia , Monitorização Transcutânea dos Gases Sanguíneos , Monitoramento de Medicamentos , Índices de Eritrócitos , Feminino , Úlcera do Pé/patologia , Úlcera do Pé/terapia , Técnicas Histológicas , Humanos , Neovascularização Fisiológica/efeitos dos fármacos , Higiene da Pele , Retalhos Cirúrgicos , Trombocitemia Essencial/sangue , Cicatrização/efeitos dos fármacos
5.
Vox Sang ; 93(1): 49-56, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17547565

RESUMO

BACKGROUND AND OBJECTIVES: The growth factors derived from platelets and plasma proteins mediate the wound-healing process that is characterized by the sequential migration and differentiation of several cell populations that give rise to angiogenesis, collagen synthesis, wound contraction, and re-epithelialization. To evaluate the efficacy of the blood-derived factors in wound healing, we examined a novel wound dressing consisting of concentrated human plasma proteins and platelet releasate (CPPP). MATERIALS AND METHODS: To generate CPPP, plasma proteins and platelets in the peripheral blood (n = 5) were concentrated with the cold ethanol precipitation method. The thrombin obtained from the same blood unit and calcium chloride (CaCl(2)) were mixed to a concentrate. The CPPP has enough strength to dress cutaneous wounds and contains large amounts of cytokines and fibronectin. We applied the CPPP to excisional skin wounds in genetically healing-impaired model mice (n= 5) and the wounds were evaluated 10 days after the operation. RESULTS: The area of CPPP-treated wounds decreased significantly compared with that of the control wounds (65% vs. 94% of the original size, respectively, P= 0.032). The immunostained section revealed a striking effect of CPPP on vascularization compared with the control wounds (13.2 vs. 2.7 vessels per mm(2) as mean vascular density observed in the sections, respectively, P= 0.013). CONCLUSIONS: Our results suggest that CPPP is a promising biologically active dressing for full-thickness skin wounds. CPPP can be an entirely autologous biological dressing, suggesting that it is free from the risk of transmission of pathogens through blood products.


Assuntos
Curativos Biológicos , Plaquetas , Proteínas Sanguíneas/uso terapêutico , Extratos Celulares/uso terapêutico , Complicações do Diabetes/terapia , Diabetes Mellitus Tipo 2/terapia , Membranas Artificiais , Dermatopatias/terapia , Pele/lesões , Animais , Plaquetas/química , Extratos Celulares/química , Complicações do Diabetes/patologia , Diabetes Mellitus Tipo 2/patologia , Modelos Animais de Doenças , Elasticidade , Humanos , Camundongos , Pele/patologia , Dermatopatias/patologia , Cicatrização , Ferimentos e Lesões/patologia , Ferimentos e Lesões/terapia
6.
Phytomedicine ; 12(5): 327-32, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15957365

RESUMO

Juzen-taiho-to (TJ-48), a mixture of extracts from 10 medicinal herbs, has been used traditionally to treat patients with anemia, anorexia or fatigue. It is well known that the treatment of TJ-48 result in the decrease of patient's complaints, as well as the increase of NK cytolytic activity (NK activity) although its augmentation is not clear in the other kampo formula from the clinical viewpoint. To investigate its biological activities, such as the augmentation of NK activity, we analyzed the effects of TJ-48 on the expression of killer-cell immunoglobulin-like receptors (KIRs) in vitro experiment. The peripheral lymphocytes were incubated in medium alone, or medium containing TJ-48 or interleukin-2 (IL-2) plus TJ-48 at several concentrations for 48 h. After each incubation, cells were collected and their KIRs were detected by flow cytometry using monoclonal antibodies CD158a and CD158b. TJ-48 increased the populations of CD16+CD158a+ and CD16+CD158b+ cells in a dose-dependent manner. In contrast, CD16-CD158a/b+ cells did not increase. Additionally, the extract of TJ-48 enhanced the increase of KIRs expression induced by IL-2. These actions contribute to the augmentation of NK cytolytic activity by TJ-48, and might explain, in part, its antitumor effects which has been observed in vivo.


Assuntos
Adjuvantes Imunológicos/farmacologia , Medicamentos de Ervas Chinesas/farmacologia , Células Matadoras Naturais/efeitos dos fármacos , Fitoterapia , Extratos Vegetais/farmacologia , Plantas Medicinais , Receptores Imunológicos/metabolismo , Adjuvantes Imunológicos/administração & dosagem , Adjuvantes Imunológicos/uso terapêutico , Antígenos CD8/efeitos dos fármacos , Antígenos CD8/metabolismo , Relação Dose-Resposta a Droga , Medicamentos de Ervas Chinesas/administração & dosagem , Medicamentos de Ervas Chinesas/uso terapêutico , Citometria de Fluxo , Humanos , Interleucina-2/farmacologia , Células Matadoras Naturais/imunologia , Células Matadoras Naturais/metabolismo , Linfócitos/efeitos dos fármacos , Linfócitos/imunologia , Linfócitos/metabolismo , Extratos Vegetais/administração & dosagem , Extratos Vegetais/uso terapêutico
7.
Phytomedicine ; 11(5): 404-10, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15330495

RESUMO

Keishi-bukuryo-gan (Gui-Zhi-Fu-Ling-Wan) (KBG) is a traditional Chinese/Japanese medical (Kampo) formulation that has been administered to patients with "Oketsu" (blood stagnation) syndrome. In the process of neuronal cell death induced by brain ischemia, excessive generation of nitric oxide (NO) free radicals is implicated in the neurotoxicity. In the present study, we examined the protective effects of KBG and its constituent medicinal plants against NO donors, sodium nitroprusside (SNP) and 2,2'-(hydroxynitrosohydrazino)bis-ethanamine (NOC18)-induced neuronal death in cultured rat cerebellar granule cells (CGCs). MTT assay showed cell viability to be significantly increased by the addition of KBG extract (KBGE) (100 microg/ml), Cinnamomi Cortex extract (CCE) (3, 10 and 30 microg/ml), Paeoniae Radix extract (PRE) (100 microg/ml) and Moutan Cortex extract (MCE) (10 and 30 microg/ml) compared with exposure to SNP (30 microM, 24 h) only. Also, cell viability was significantly increased by the addition of KBGE (100 and 300 microg/ml), CCE (30 and 100 microg/ml), PRE (100 and 300 microg/ml) and MCE (30 and 100 microg/ml) compared with exposure to NOC 18 (100 microM, 48 h) only. Persicae Semen extract and Hoelen extract did not protect against NO donor-induced neuronal death. These results suggest that KBG has protective effect against NO-mediated neuronal death in cultured CGCs and that it is derived from Cinnamomi Cortex, Paeoniae Radix and Moutan Cortex.


Assuntos
Cerebelo/efeitos dos fármacos , Medicamentos de Ervas Chinesas/farmacologia , Fitoterapia , Plantas Medicinais , Substâncias Protetoras/farmacologia , Animais , Isquemia Encefálica/induzido quimicamente , Isquemia Encefálica/prevenção & controle , Sobrevivência Celular/efeitos dos fármacos , Cerebelo/citologia , Cinnamomum , Medicamentos de Ervas Chinesas/administração & dosagem , Medicamentos de Ervas Chinesas/uso terapêutico , Nitroprussiato , Compostos Nitrosos , Paeonia , Polyporales , Substâncias Protetoras/administração & dosagem , Substâncias Protetoras/uso terapêutico , Prunus , Ratos , Ratos Wistar
8.
Phytomedicine ; 11(2-3): 188-95, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15070171

RESUMO

Keishi-bukuryo-gan (Gui-zhi-fu-ling-wan) is a formula used for the improvement of blood circulation. Recently it has often also been used for arteriosclerosis. One of the mechanisms involved is thought to be the improvement of endothelial dysfunction, but the details are still unclear. In this study, the effect of Keishi-bukuryo-gan on vascular function and hemorheological factors in spontaneously diabetic (WBN/kob) rats was studied. Rats were given Keishi-bukuryo-gan in chow for 30 weeks. Body weight, blood glucose, endothelium-dependent/-independent relaxation, vasocontraction by free radical-induced and contractive prostanoids, triglyceride, advanced glycation endproduct, lipid peroxides, serum NO2-/NO3- and blood viscosity were measured. The results indicated that Keishi-bukuryo-gan caused a decrease in endothelium-dependent relaxation by acetylcholine to become significantly increased, and vasocontraction induced by free radicals and contractive prostanoids was significantly decreased. Furthermore, serum NO2-/NO3- and blood viscosity were significantly decreased. From these results, it was supposed that Keishi-bukuryo-gan exerted a protective effect on the endothelium. The WBN/kob rat is a useful study model for the complications of human diabetes, and Keishi-bukuryo-gan showed a protective effect against vascular injury in the susceptible rat.


Assuntos
Medicamentos de Ervas Chinesas , Medicamentos de Ervas Chinesas/farmacologia , Fitoterapia , Vasodilatadores/farmacologia , Administração Oral , Ração Animal , Animais , Arteriosclerose/prevenção & controle , Glicemia/efeitos dos fármacos , Viscosidade Sanguínea/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Medicamentos de Ervas Chinesas/administração & dosagem , Medicamentos de Ervas Chinesas/uso terapêutico , Masculino , Nitratos/sangue , Prostaglandinas , Distribuição Aleatória , Ratos , Ratos Endogâmicos , Ratos Wistar , Triglicerídeos/metabolismo , Vasodilatação/efeitos dos fármacos , Vasodilatadores/administração & dosagem , Vasodilatadores/uso terapêutico
9.
Phytomedicine ; 11(1): 5-10, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-14971716

RESUMO

We found that a herbal medicine (Mao-to) relieves the side effects of interferon (IFN)-beta and the combination therapy improves the biochemical response rate. However, the exact mechanism by which Mao-to is effective remains to be established. We conducted a controlled trial to clarify the effects of Mao-to. The study was carried out in 18 patients with chronic hepatitis C, and we examined subjective symptoms, body temperature and cytokines such as interleukin (IL)-beta, IL-1receptor antagonist (ra), IL-6 and TNF-alpha. Each patient received 6 million units of IFN-beta intravenously. Mao-to was given orally just before, just after, and 1 hour after IFN administration. The control study was carried out 6 months after the combination therapy of Mao-to and IFN-beta. The scores for general malaise, arthralgia and discomfort were significantly lower in the combination group than in control group. Body temperature did not significantly differ between the two groups. Plasma IL-6 level and IL-1ra were significantly elevated in the combination group compared to control (P = 0.0057 and 0.0003, respectively). Mao-to did not affect plasma concentrations of IL-1beta and TNF-alpha. We considered the increment of IL-1ra caused by Mao-to is to be one of the key factors involved in reducing the flu-like symptoms accompanying IFN-beta and improving the biochemical response rate.


Assuntos
Medicamentos de Ervas Chinesas/uso terapêutico , Hepatite C Crônica/tratamento farmacológico , Fatores Imunológicos/uso terapêutico , Interferon beta/uso terapêutico , Fitoterapia , Plantas Medicinais , Adulto , Idoso , Temperatura Corporal , Citocinas/sangue , Quimioterapia Combinada , Medicamentos de Ervas Chinesas/administração & dosagem , Feminino , Hepatite C Crônica/imunologia , Humanos , Fatores Imunológicos/administração & dosagem , Infusões Intravenosas , Interferon beta/administração & dosagem , Proteína Antagonista do Receptor de Interleucina 1 , Interleucina-1/sangue , Interleucina-6/sangue , Masculino , Pessoa de Meia-Idade , Sialoglicoproteínas/sangue , Fator de Necrose Tumoral alfa/metabolismo
10.
Phytomedicine ; 10(6-7): 459-66, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-13678228

RESUMO

Keishi-bukuryo-gan (Gui-Zhi-Fu-Ling-Wan) (KBG) is one of the prescriptions in Japanese traditional medicine for improving the "oketsu" syndrome, so-called blood stasis syndrome. "Oketsu" syndrome is an important pathological conception in Japanese traditional medicine and often accompanies cerebro-vascular disorders. Previously, we were able to reveal a deterioration of RBC (Red blood cell) deformability and viscoelasticity in patients with "oketsu" syndrome. The purpose of the present study was to evaluate whether KBG has an effect on RBC deformability in comparison with pentoxifylline (PXF). The subjects were 30 male patients with multiple lacunar infarctions. Eighteen patients (44-79 yrs, mean +/- SD, 66.1 +/- 10.7 yrs) were treated with 12 g of KBG daily for 4 weeks (KBG group). Twelve patients (59-78 yrs, 70.7 +/- 6.4 yrs) were treated with 300 mg of PXF daily for 4 weeks (PXF group). Based on the "oketsu" score, the patients of each group were divided into two subgroups, a non-"oketsu" group ("oketsu" score 20 points or less) and an "oketsu" group ("oketsu" score 21 points or higher). KBG had significant effects on RBC deformability as evaluated by filtration method. KBG also significantly increased intracellular ATP content, as did PXF. Moreover, KBG was more effective for patients with a more severe "oketsu" state. However, PXF was effective only in patients with "oketsu" syndrome, who might have deteriorated RBC deformability. In conclusion, the effect of KBG on RBC deformability was by no means inferior to PXF.


Assuntos
Infarto Cerebral/tratamento farmacológico , Medicamentos de Ervas Chinesas/uso terapêutico , Deformação Eritrocítica/efeitos dos fármacos , Pentoxifilina/uso terapêutico , Fitoterapia , Inibidores da Agregação Plaquetária/uso terapêutico , Administração Oral , Adulto , Idoso , Infarto Cerebral/patologia , Cromatografia Líquida de Alta Pressão , Medicamentos de Ervas Chinesas/administração & dosagem , Medicamentos de Ervas Chinesas/farmacologia , Hemólise/efeitos dos fármacos , Humanos , Japão , Masculino , Medicina Tradicional , Pessoa de Meia-Idade , Pentoxifilina/administração & dosagem , Pentoxifilina/farmacologia , Inibidores da Agregação Plaquetária/administração & dosagem , Inibidores da Agregação Plaquetária/farmacologia , Índice de Gravidade de Doença , Resultado do Tratamento
11.
Phytomedicine ; 10(2-3): 122-6, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12725564

RESUMO

Using a high-performance liquid chromatographic method and mass spectrometry analysis, we successfully measured the absorption of orally administered procyanidin B-2 and procyanidin B-3 isolated from Cinnamonomi cortex (the bark of Cinnamomum cassia Blume) in the rat plasma. This method used a TSK- GEL ODS-80TS column, two solvents (A: 0.01% acetic acid; B: methanol with 0.01% acetic acid) in a linear gradient at a flow-rate of 1.0 ml/min, and fluorescence detection at excitation and emission wavelengths of 220 and 327 nm.


Assuntos
Biflavonoides , Catequina/farmacologia , Cinnamomum aromaticum , Proantocianidinas , Administração Oral , Animais , Catequina/sangue , Catequina/química , Cromatografia Líquida de Alta Pressão , Masculino , Espectrometria de Massas , Extratos Vegetais/farmacologia , Ratos , Ratos Wistar , Fatores de Tempo
12.
Phytomedicine ; 9(7): 636-40, 2002 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12487328

RESUMO

The present study is designed to test our hypothesis that the ingestion of Uncaria sinensis (US), the main medicinal plant of Choto-san (Diao-teng-san, CS), would protect red blood cell (RBC) membrane from free radical-induced oxidation if polyphenolics in US could be absorbed and circulated in blood. When incubated with RBC suspension, Choto-san extract (CSE) and Uncaria sinensis extract (USE) exhibited strong protection for RBC membrane against hemolysis induced by 2,2-azo-bis (2-amidinopropane) dihydrochloride (AAPH), an azo free-radical initiator. The inhibitory effect was dose-dependent at concentrations of 50 to 1000 microg/mL. Ingestion of 200 mg of USE was associated with a significant decrease in susceptibility of RBC to hemolysis in rats. Furthermore, caffeic acid, an antioxidative hydroxycinnamic acid, was identified in rat plasma after administration of URE.


Assuntos
Medicamentos de Ervas Chinesas , Eritrócitos/efeitos dos fármacos , Hemólise/efeitos dos fármacos , Extratos Vegetais/farmacologia , Caules de Planta/química , Uncaria , Amidinas/farmacologia , Animais , Relação Dose-Resposta a Droga , Radicais Livres/efeitos adversos , Masculino , Ratos , Ratos Wistar
13.
Phytomedicine ; 9(5): 455-60, 2002 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12222668

RESUMO

Oren-gedoku-to (Huanglian-Jie-Du-Tang, OGT) has been used for the treatment of cerebrovascular disease, hypertension, gastritis and liver disease in Japan. The present study was to test whether ingestion of OGT extract (TJ-15) would affect the metabolism of fatty acids and the usual antioxidant molecule (such as albumin, uric acid and bilirubin) levels in human plasma. After the administration of TJ-15, plasma total cholesterol and the triglyceride level significantly decreased, and lipoprotein lipase mass increased. Significant enhancement of plasma albumin level and reduction of the total plasma protein level resulted in an increment of the albumin/globulin ratio. Plasma fibrinogen, an independent risk factor for cerebrovascular disease, declined considerably, but the reduction was not statistically significant. The findings of this study suggest that ingestion of TJ-15 improves the microcirculation through lipid and protein metabolisms, and is useful for the treatment of cerebral vascular attack in human.


Assuntos
Medicamentos de Ervas Chinesas/administração & dosagem , Albumina Sérica/metabolismo , Triglicerídeos/sangue , Cromatografia Líquida de Alta Pressão , Ensaio de Imunoadsorção Enzimática , Humanos , Masculino
14.
Phytomedicine ; 9(3): 195-201, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12046858

RESUMO

Two published case reports described palliation of disease after Seihai-to therapy for refractory aspiration pneumonia caused by recurrent laryngeal nerve paralysis and cerebrovascular disease. We undertook an open-label trial in patients with relapsing aspiration pneumonia. Fifteen patients with relapsing aspiration pneumonia were randomly divided into conventional therapy group (n = 8) or Seihai-to group (n = 7). In Seihai-to group, patients were treated with Seihai-to in addition to conventional therapy (Western medicines). Frequency of feverish days and antibiotics-use, CRP value and chest CT or X-ray findings were compared between the two groups during the study period of 16 weeks. In the Seihai-to group, the latency of swallowing reflex was measured in 6 patients before and after administration of Seihai-to. The mean values of fever index, CRP value and antibiotics-use in the Seihai-to group were decreased significantly, compared with those of the conventional therapy group. However, the latency of the swallowing reflex after 4 weeks of treatment was not significantly changed (p = 0.249), compared with the latency before administration of Seihai-to. No adverse reaction was observed in either group. Seihai-to was effective in reducing relapse of aspiration pneumonia in this small group. Seihai-to might not improve the swallowing reflex, but might instead improve a defense mechanism or excessive inflammation caused by pneumonia in the lower airway. Further evaluation of Seihai-to therapy for patients with aspiration pneumonia in a larger population is warranted.


Assuntos
Medicamentos de Ervas Chinesas/uso terapêutico , Fitoterapia , Pneumonia Aspirativa/tratamento farmacológico , Idoso , Idoso de 80 Anos ou mais , Deglutição/fisiologia , Medicamentos de Ervas Chinesas/administração & dosagem , Feminino , Humanos , Pacientes Internados , Masculino , Medicina Kampo , Cuidados Paliativos , Projetos Piloto , Pneumonia Aspirativa/diagnóstico por imagem , Pneumonia Aspirativa/patologia , Estudos Prospectivos , Recidiva , Reflexo/fisiologia , Tomografia Computadorizada por Raios X , Resultado do Tratamento
15.
Am J Chin Med ; 27(3-4): 339-45, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10592842

RESUMO

The protective effect of the extract of Uncariae ramulus et Uncus (URE) against endothelium disorder due to hypertension was investigated. We administered low (150 mg/kg/day) and high (450 mg/kg/day) doses of URE orally to spontaneously hypertensive rats for 8 weeks. Endothelium dependent vasodilatation by acetylcholine increased significantly in the high URE group compared with the control group. Endothelium dependent vasocontraction by xanthine oxidase decreased significantly in the high URE group compared with the control group. Serum NO2-/NO3- were tended to increase in the high URE group. It is suggested that URE may have a protective effect for the endothelium against the influence of hypertension.


Assuntos
Endotélio Vascular/efeitos dos fármacos , Músculo Liso Vascular/efeitos dos fármacos , Plantas Medicinais/química , Acetilcolina/farmacologia , Animais , Técnicas In Vitro , Contração Isométrica/efeitos dos fármacos , Contração Muscular/efeitos dos fármacos , Relaxamento Muscular/efeitos dos fármacos , Nitratos/metabolismo , Óxido Nítrico/metabolismo , Nitritos/metabolismo , Ratos , Ratos Endogâmicos SHR , Fatores de Tempo , Xantina Oxidase/antagonistas & inibidores , Xantinas/farmacologia
16.
Phytother Res ; 13(3): 192-6, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10353155

RESUMO

In this study, we examined whether in vivo keishi-bukuryo-gan (a Kampo formulation) could prevent the progression of atherosclerosis in cholesterol-fed rabbits, an animal model for hypercholesterolaemia. Sixteen male Japanese white rabbits (2 kg body weight) were divided into two groups. Group A (n = 8) was fed standard rabbit chow containing 1% cholesterol for 8 weeks. Group B (n = 8) was fed standard rabbit chow containing 1% cholesterol and 1% keishi-bukuryo-gan for 8 weeks. At the end of the experiment, average plasma concentrations of total-cholesterol and IDL-cholesterol were 2055.9 +/- 201.8 mg/dL and 408.1 +/- 62.6 mg/dL in group A and 1950.5 +/- 126.3 mg/dL and 407.6 +/- 56.6 mg/dL in group B, respectively. The percentage of the surface area of the total thoracic aorta with visible plaque was significantly reduced by keishi-bukuryo-gan administration; group A was 33.2% +/- 5.3% and group B was 14.3% +/- 2.9%. beta-very low density lipoprotein (VLDL) and low density lipoprotein (LDL) isolated from cholesterol fed rabbits treated with keishi-bukuryo-gan (group B) were shown to be highly resistant to oxidative modification by cupric ion. Sera isolated from rabbits administered keishi-bukuryo-gan had reduced lipid peroxide formation compared with those from rabbits without keishi-bukuryo-gan. Thus, keishi-bukuryo-gan prevents the progression of atherosclerosis in cholesterol-fed rabbits in vivo by limiting oxidative LDL modification.


Assuntos
Arteriosclerose/tratamento farmacológico , Colesterol na Dieta/administração & dosagem , Medicamentos de Ervas Chinesas/uso terapêutico , Animais , Arteriosclerose/sangue , Arteriosclerose/etiologia , Peso Corporal , LDL-Colesterol/sangue , VLDL-Colesterol/sangue , Medicamentos de Ervas Chinesas/farmacologia , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Coelhos
17.
Gait Posture ; 7(3): 225-227, 1998 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-10200388

RESUMO

The walk ratio, step-length divided by step-rate, is a speed-independent index of walking patterns. This study reports on the reproducibility of the walk ratio in repeated tests. A total of 25 healthy young subjects walked on a flat floor at five different speeds and the test was repeated on the same day and after 3 months. The walk ratio did not vary in the tests. Intraclass correlation coefficients of the walk ratio between the tests were 0.6-0.8 except for walking at extreme speeds. These results suggest that the walk ratio is a reliable measure for evaluating pathological and aging walking patterns. Copyright 1998 Elsevier Science B.V. All rights reserved

18.
J Orthop Sports Phys Ther ; 26(5): 266-72, 1997 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9353690

RESUMO

The optimal condition in speed, step rate, and step length of human walking has been reported in terms of temporal consistency, energy cost, and attentional demand. No study, however, has been conducted on the optimal condition in terms of spatial variability of walking. This study examined whether there is an optimal walking speed with minimum intrasubject variability in step length and step width during free walk (experiment 1) and whether there is an optimal step rate with minimum step length variability during walking with imposed step rates (experiment 2). Wearing shoes with ink-applied felt squares attached to the heels, healthy students walked on a flat walkway (0.6 x 16 m) at five different speeds with a freely chosen step rate in experiment 1 and walked at three different speeds with five different step rates in experiment 2. Free walk was found to have the fewest variable errors (VEs) in step length approximately at preferred walking speed. Variable error in step width increased linearly with an increase in walking speed. Under imposed step rates, VEs in step length were the fewest when walking with step rates close to those in free walk. Our everyday walking is performed most frequently at preferred speed and/or with freely chosen step rate, thereby optimizing the consistency of gait performance. Intrasubject variability in step length may be a useful measure for evaluation of walking.


Assuntos
Marcha , Adulto , Análise de Variância , Feminino , Marcha/fisiologia , Humanos , Masculino
19.
J Gravit Physiol ; 4(1): S31-6, 1997 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11541173

RESUMO

Gender differences in the effect of 20 days bed rest (BR) on muscle strength were evaluated in voluntary 11 male and 7 female students. Maximum Isometric Voluntary Contractions (MVC) of 4 right arm muscles (RAM), 5 right leg muscles (RLM), and 2 body trunk muscles were measured with an isometric dynamometer, respectively. Muscle masses (MM) of right arm and leg and body trunk were determined by dual energy X-ray absorptiometry, respectively. The maximum cross sectional area (CSAmax) of right m. quadriceps femoris was measured by magnetic resonance imaging. Elbow flexion MVC in males and all MVC of RLM except knee flexion in both males and females were decreased (p<0.05), but elbow extension MVC in females was increased (p<0.05), while all of other MVC only tended to decrease. However, the decrements in leg MVC were not correlated to the leg MM, and also the decrement in knee extension was not correlated to the CSAmax of m. quadriceps. The reduction of MVC of antigravity muscles might be caused not only by a decrease in MM but also by other factors. The greater decrements of leg MVC during BR were the higher initial level in males, but the inverse was observed in females. However, this discrepancy between males and females cannot be explained in the present study.


Assuntos
Repouso em Cama , Contração Muscular/fisiologia , Músculo Esquelético/fisiologia , Adolescente , Adulto , Braço , Articulação do Cotovelo/fisiologia , Feminino , Humanos , Articulação do Joelho/fisiologia , Perna (Membro) , Masculino , Músculo Esquelético/anatomia & histologia , Fatores Sexuais , Coxa da Perna
20.
J Gravit Physiol ; 4(1): S41-5, 1997 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11541175

RESUMO

The effects of 20 days horizontal bed rest (BR) on postural reflex were studied by measuring fluctuation of center of gravity in the body during two legs or one leg upright standing in 10 young volunteers. The fluctuation was decided as total moving distance of the center recorded during 60sec standing on a force plate. The stability was measured by the moved area. After BR, the moving distance increased during two legs standing with open eyes (p<0.05), but statistically unchanged with closed eyes. The moving area decreased during right one-leg standing with closed eyes (p<0.05), but unchanged during left one-leg standing. Despite with open eyes the increased distance suggested that postural reflexes to maintain upright position were probably decreased by increased unsuitable feedback informations from the visual receptor deconditioning during BR. The decreased area during right one-leg standing with closed eyes also suggested that the declined standing posture reflex was probably related to more rapidly lowered functions for maintaining standing position in the dominating leg than in the other.


Assuntos
Repouso em Cama , Gravitação , Postura/fisiologia , Adulto , Feminino , Humanos , Perna (Membro) , Masculino , Equilíbrio Postural , Percepção Visual
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...